Order Article Reprints

Xu Z, Huang A, Luo X, Zhang P, Huang L, Wang X, Mi K, Fang S, Huang X, Li J, et al. Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF. Antibiotics. 2021; 10(7):808. https://doi.org/10.3390/antibiotics10070808

Xu, Zihui, Anxiong Huang, Xun Luo, Peng Zhang, Lingli Huang, Xu Wang, Kun Mi, Shiwei Fang, Xiao Huang, Jun Li, and et al. 2021. "Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF" Antibiotics 10, no. 7: 808. https://doi.org/10.3390/antibiotics10070808

Xu, Z., Huang, A., Luo, X., Zhang, P., Huang, L., Wang, X., Mi, K., Fang, S., Huang, X., Li, J., Yuan, Z., & Hao, H. (2021). Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF. Antibiotics, 10(7), 808. https://doi.org/10.3390/antibiotics10070808